In U.S. hospitals, the frequency of brain imaging for acute stroke patients dipped, suggesting hesitancy to seek medical care for non-COVID-19 conditions.
A Stanford team is developing a bioscaffold that helps insulin-producing cells get enough oxygen when transplanted for diabetes treatment.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
Based on new technologies and improved understanding, physicians are no longer recommending routine use of radioprotective shields for X-ray procedures.
A NOVA special featured Rhiju Das and the OpenVaccine project, in which gamers help scientists find an RNA molecule configuration for a COVID-19 vaccine.
Using microbubbles and ultrasound, researchers have created a cancer treatment that kills tumor cells and recruits immune cells to the tumor.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
There's a lot we can do to improve brain health and counteract genetic factors for memory loss, Stanford neuroscientist Sharon Sha says in a podcast.
This New York Times video showcases Stanford Medicine's efforts to offer COVID-19 antibody tests to its doctors, nurses and other clinical workers.
Even if chloroquine and hydroxychloroquine don't end up being the best treatment for COVID-19, observing how they work in a dish can teach scientists a lot.
Research shows that misshapen proteins called prions can help yeast cells survive environmental threats, such as a lack of food and common antifungal drugs.
Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors.
Stanford researchers are devising new ways to tackle cancer through better, more sophisticated diagnostics and treatments.
A Stanford neurologist and her colleagues are zeroing in on identifying causes and treatments for chemo brain.
Stanford Medicine will be the first to use a new technology that aims to heighten precision of radiation therapy in cancer patients.